Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile.

Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Abstract Text:

Lindsey A Kerr,

Stress urinary incontinence (SUI) can be defined as involuntary loss of urine during a period of increased abdominal pressure and in the absence of detrusor activity. Bulking agents used in the urethra are one of the newer but established technologies for the treatment of SUI. An understanding of the demographics of SUI will help in the selection of patients for bulking agent therapy. Knowledge of available materials, including their positive and negative aspects, is also required. Autologous fat, silicone beads, collagen, carbon particles, and polytetrafluoroethylene paste have all demonstrated success to some degree, but none have met both criteria for success (remaining efficacious over time and maintaining a low side-effect profile). An implantable solution of ethylene vinyl alcohol suspended in dimethyl sulfoxide, currently in clinical testing and review, shows minimal foreign body reaction and is one option being investigated to address patient needs for improved bulking therapy.

Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Publishing Authors By Initials

LA Kerr,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Reviews in urology

VOLUME: 7 Suppl 1

Page Numbers: S3-S11

Journal Abbreviation:

ISSN: 1523-6161

DAY: 20

MONTH: 09

YEAR: 2005

Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100889067

Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Rev Urol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile Related Publications

• 2006 rare neuroimmunological disorders symposium; Sheraton Inner Harbor, Baltimore, MD, July 20-23, 2006.
• Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver.
• Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile.
• Can an expanded and integrated occupational health service help buffer the impact of a global influenza outbreak in healthcare organizations?
• Can nurses apply the Canadian C-Spine Rule? A pilot study.
• Demonstration of 5-HT(3) receptor function and expression in the mouse bladder.
• Diprosopus with multiple craniofacial, musculoskeletal, and cardiac defects in a purebred Suffolk lamb.
• Diversity of the bacterial communities associated with the azooxanthellate deep water octocorals Leptogorgia minimata, Iciligorgia schrammi, and Swiftia exertia.
• Domoic acid preconditioning and seizure induction in young and aged rats.
• Elevated syringe borrowing among men who have sex with men: a prospective study.
• Examination of homo-[3 + 2]-dipolar cycloaddition: mechanistic insight into regio- and diastereoselectivity.
• Factors Affecting Rural Medicine: an improvement on the Rurality Index of Ontario.
• First, do no harm: A modern approach to the holistic management of keratoconus.
• FloWatch versus conventional pulmonary artery banding.
• Frequent needle exchange use and HIV incidence in Vancouver, Canada.
• Global warming. How urgent is climate change?
• Hip Pain-Football: 1100: June 1 9:20 AM 9:40 AM.
• Imaging the activity of neurons and muscles.
• Income generating activities of people who inject drugs.
• Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease.
• Isodomoic acids A and C exhibit low KA receptor affinity and reduced in vitro potency relative to domoic acid in region CA1 of rat hippocampus.
• Knee Injury - Soccer: 988: May 30 10:30 AM - 10:50 AM.
• Lactate response in anaerobic and aerobic athletes and sedentary individuals: 1605: board #95 may 30 2:00 PM - 3:30 PM.
• Overcoming the influence of chronic pain on older patients' difficulty with recommended self-management activities.
• Planetary science. Majority rules in finding a path for the next Mars Rover.
• Planning and control of sequential rapid aiming in adults with Parkinson's disease.
• Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth.
• The cycloaddition of nitrones with homochiral cyclopropanes.
• The diversity of the bacterial communities associated with the azooxanthellate hexacoral Cirrhipathes lutkeni.
• Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.